欧洲-话题@MedSci

#欧洲#

592篇内容 | 6073人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1339163, encodeId=f6cf1339163eb, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=欧洲发布肥胖指南：减腰围比减体重更重要！, objectType=article, longId=160783, objectId=a32e160e8357, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a32e160e8357, replyNumber=0, likeNumber=79, createdTime=2019-02-23, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a32e160e8357, moduleTitle=欧洲发布肥胖指南：减腰围比减体重更重要！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a32e160e8357)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339162, encodeId=c20213391629c, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=辉瑞的Avastin生物仿制药——ZIRABEV在欧洲获批治疗多个转移性肿瘤, objectType=article, longId=160659, objectId=32b11606595c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b11606595c, replyNumber=0, likeNumber=66, createdTime=2019-02-22, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b11606595c, moduleTitle=辉瑞的Avastin生物仿制药——ZIRABEV在欧洲获批治疗多个转移性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b11606595c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339161, encodeId=a1f813391612c, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2019 欧洲CTO俱乐部共识文件：慢性完全闭塞经皮再通术, objectType=article, longId=160474, objectId=a61d1604e444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a61d1604e444, replyNumber=0, likeNumber=12, createdTime=2019-02-20, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a61d1604e444, moduleTitle=2019 欧洲CTO俱乐部共识文件：慢性完全闭塞经皮再通术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a61d1604e444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339160, encodeId=bd3413391601c, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2019 欧洲实践指南：基层医疗中成人肥胖的管理, objectType=article, longId=159383, objectId=a55e159383e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a55e159383e3, replyNumber=0, likeNumber=14, createdTime=2019-02-03, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a55e159383e3, moduleTitle=2019 欧洲实践指南：基层医疗中成人肥胖的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a55e159383e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339159, encodeId=ea591339159ea, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=欧洲药品管理局在英国脱欧前搬离伦敦, objectType=article, longId=159136, objectId=4cde159136d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cde159136d8, replyNumber=0, likeNumber=77, createdTime=2019-01-30, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cde159136d8, moduleTitle=欧洲药品管理局在英国脱欧前搬离伦敦, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cde159136d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339158, encodeId=81a3133915815, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=礼来制药获得欧洲加速审批的软组织癌症药物Lartruvo三期临床失败, objectType=article, longId=159004, objectId=fb33159004d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb33159004d7, replyNumber=0, likeNumber=59, createdTime=2019-01-28, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb33159004d7, moduleTitle=礼来制药获得欧洲加速审批的软组织癌症药物Lartruvo三期临床失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb33159004d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339157, encodeId=388f133915e03, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定, objectType=article, longId=158995, objectId=d85315899529, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85315899529, replyNumber=0, likeNumber=15, createdTime=2019-01-28, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85315899529, moduleTitle=Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85315899529)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339156, encodeId=606e133915630, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Clovis Oncology宣布欧洲委员会批准Rubraca用于复发性卵巢癌的维持治疗, objectType=article, longId=158910, objectId=54ad1589109b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54ad1589109b, replyNumber=0, likeNumber=45, createdTime=2019-01-27, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54ad1589109b, moduleTitle=Clovis Oncology宣布欧洲委员会批准Rubraca用于复发性卵巢癌的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54ad1589109b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339155, encodeId=b0521339155b8, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Circ: Cardiovasc Inte：根据手术风险一个欧洲经导管主动脉瓣植入队列的1年结局, objectType=article, longId=158483, objectId=32ea15848310, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32ea15848310, replyNumber=0, likeNumber=99, createdTime=2019-01-22, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32ea15848310, moduleTitle=Circ: Cardiovasc Inte：根据手术风险一个欧洲经导管主动脉瓣植入队列的1年结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32ea15848310)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339154, encodeId=60fb1339154cd, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读, objectType=article, longId=157503, objectId=8f8415e503af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f8415e503af, replyNumber=0, likeNumber=17, createdTime=2019-01-08, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f8415e503af, moduleTitle=玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f8415e503af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339153, encodeId=411c133915353, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle="PANDA"登陆巴黎！康柏西普全球多中心III期临床试验欧洲区研究者大会召开, objectType=article, longId=156456, objectId=54b315645636, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54b315645636, replyNumber=0, likeNumber=60, createdTime=2018-12-24, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54b315645636, moduleTitle="PANDA"登陆巴黎！康柏西普全球多中心III期临床试验欧洲区研究者大会召开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54b315645636)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339152, encodeId=b1e91339152fd, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2018 欧洲共识建议：罕见儿童血管炎的诊断和治疗, objectType=article, longId=156428, objectId=3520156428c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3520156428c6, replyNumber=0, likeNumber=17, createdTime=2018-12-24, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3520156428c6, moduleTitle=2018 欧洲共识建议：罕见儿童血管炎的诊断和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3520156428c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339151, encodeId=85c913391514c, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=欧洲复苏委员会复苏指南：2018更新-心脏骤停中的抗心律失常药物, objectType=article, longId=156216, objectId=24e2156216e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24e2156216e6, replyNumber=0, likeNumber=52, createdTime=2018-12-21, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24e2156216e6, moduleTitle=欧洲复苏委员会复苏指南：2018更新-心脏骤停中的抗心律失常药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24e2156216e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339150, encodeId=f253133915067, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2018 欧洲共识建议：川崎病的诊断和治疗, objectType=article, longId=156138, objectId=a83115613849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a83115613849, replyNumber=0, likeNumber=23, createdTime=2018-12-20, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a83115613849, moduleTitle=2018 欧洲共识建议：川崎病的诊断和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a83115613849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339149, encodeId=63441339149ed, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=受管制审批延误欧洲抗癌新药上市要等多年, objectType=article, longId=155200, objectId=9a2d15520066, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a2d15520066, replyNumber=0, likeNumber=59, createdTime=2018-12-07, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a2d15520066, moduleTitle=受管制审批延误欧洲抗癌新药上市要等多年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a2d15520066)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339148, encodeId=d8fe133914856, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2018 EARCS欧洲共识：直肠癌标准化机器人全肠系膜切除术, objectType=article, longId=155139, objectId=91e015513965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91e015513965, replyNumber=0, likeNumber=18, createdTime=2018-12-06, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91e015513965, moduleTitle=2018 EARCS欧洲共识：直肠癌标准化机器人全肠系膜切除术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91e015513965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339147, encodeId=1ea1133914e22, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=JAMA：2018欧洲和2017美国高血压指南默契多还是分歧多？, objectType=article, longId=154641, objectId=f6c1154641d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6c1154641d2, replyNumber=0, likeNumber=59, createdTime=2018-12-01, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6c1154641d2, moduleTitle=JAMA：2018欧洲和2017美国高血压指南默契多还是分歧多？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6c1154641d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339146, encodeId=212f1339146e5, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=JAMA： 2018欧洲和2017美国高血压指南默契多还是分歧多？, objectType=article, longId=154629, objectId=aaf8154629bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaf8154629bb, replyNumber=0, likeNumber=65, createdTime=2018-12-01, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaf8154629bb, moduleTitle=JAMA： 2018欧洲和2017美国高血压指南默契多还是分歧多？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaf8154629bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339145, encodeId=a1f3133914516, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=BMJ：英国与欧洲其他国家呼吸道疾病死亡率比较, objectType=article, longId=154624, objectId=4c9d15462498, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c9d15462498, replyNumber=0, likeNumber=91, createdTime=2018-11-30, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c9d15462498, moduleTitle=BMJ：英国与欧洲其他国家呼吸道疾病死亡率比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c9d15462498)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339144, encodeId=e5f1133914424, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=2018欧洲共识建议：乳腺癌治疗决策中易感基因的遗传咨询和检测, objectType=article, longId=154598, objectId=d88315459889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88315459889, replyNumber=0, likeNumber=16, createdTime=2018-11-30, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88315459889, moduleTitle=2018欧洲共识建议：乳腺癌治疗决策中易感基因的遗传咨询和检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88315459889)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

欧洲

2020-05-29

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

欧洲发布肥胖指南：减腰围比减体重更重要！

2019-02-23

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

辉瑞的Avastin生物仿制药——ZIRABEV在欧洲获批治疗多个转移性肿瘤

2019-02-22

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

2019 欧洲CTO俱乐部共识文件：慢性完全闭塞经皮再通术

2019-02-20

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

2019 欧洲实践指南：基层医疗中成人肥胖的管理

2019-02-03

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

欧洲药品管理局在英国脱欧前搬离伦敦

2019-01-30

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

礼来制药获得欧洲加速审批的软组织癌症药物Lartruvo三期临床失败

2019-01-28

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定

2019-01-28

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Clovis Oncology宣布欧洲委员会批准Rubraca用于复发性卵巢癌的维持治疗

2019-01-27

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Circ: Cardiovasc Inte：根据手术风险一个欧洲经导管主动脉瓣植入队列的1年结局

2019-01-22

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读

2019-01-08

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

"PANDA"登陆巴黎！康柏西普全球多中心III期临床试验欧洲区研究者大会召开

2018-12-24

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

2018 欧洲共识建议：罕见儿童血管炎的诊断和治疗

2018-12-24

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

欧洲复苏委员会复苏指南：2018更新-心脏骤停中的抗心律失常药物

2018-12-21

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

2018 欧洲共识建议：川崎病的诊断和治疗

2018-12-20

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

受管制审批延误欧洲抗癌新药上市要等多年

2018-12-07

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

2018 EARCS欧洲共识：直肠癌标准化机器人全肠系膜切除术

2018-12-06

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

JAMA：2018欧洲和2017美国高血压指南默契多还是分歧多？

2018-12-01

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

JAMA： 2018欧洲和2017美国高血压指南默契多还是分歧多？

2018-12-01

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

BMJ：英国与欧洲其他国家呼吸道疾病死亡率比较

2018-11-30

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

2018欧洲共识建议：乳腺癌治疗决策中易感基因的遗传咨询和检测

2018-11-30

科室
- - 订阅+
  - 更多科室
工具
服务